| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |